Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding hemostasis , control leaking sealant and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self assembling barrier technology platform with the goal of making care faster and safer for patients. Arch s development stage product candidates include the AC Topical Gel and the AC Surgical Hemostatic Device.
Quote | Arch Therapeutics Inc (OTCMKTS:ARTH)
Last: | $1.16 |
---|---|
Change Percent: | 1.57% |
Open: | $1.1 |
Close: | $1.16 |
High: | $1.2 |
Low: | $1.1 |
Volume: | 1,883 |
Last Trade Date Time: | 04/17/2024 03:00:00 am |
News | Arch Therapeutics Inc (OTCMKTS:ARTH)
Spark New Zealand Limited ADR (SPKKY) is expected to report for Q1 2024 Taylor Devices Inc. (TAYD) is expected to report for Q1 2024 American Biltrite Inc. (ABLT) is expected to report for quarter end 2023-09-30 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for Q3 2024 ...
1st Cap Bancorp (FISB) is expected to report for Q3 2023 Timberline Resources Corp. (TLRS) is expected to report for Q1 2024 Engie Brasil Energia S.A. ADR (EGIEY) is expected to report for Q4 2023 NuZee Inc. (NUZE) is expected to report for quarter end 2023-09-30 Global Arena Hold...
Message Board Posts | Arch Therapeutics Inc (OTCMKTS:ARTH)
Subject | By | Source | When |
---|---|---|---|
Waiting for revenue numbers instead of conference presentations. | Polyphemus | investorshub | 04/26/2023 8:23:43 PM |
What a piece of Shat...Great job Terry | moneymaker290 | investorshub | 04/21/2023 10:20:01 PM |
I barely hold any shares and its almost | tfris | investorshub | 04/14/2023 2:30:18 PM |
3 years post FDA clearance & TN tries | Polyphemus | investorshub | 03/08/2023 6:54:38 PM |
Market Cap $4.1M & falling. | Polyphemus | investorshub | 02/13/2023 7:12:13 PM |
News, Short Squeeze, Breakout and More Instantly...
Arch Therapeutics Inc Company Name:
ARTH Stock Symbol:
OTCMKTS Market:
Arch Therapeutics Inc Website:
Spark New Zealand Limited ADR (SPKKY) is expected to report for Q1 2024 Taylor Devices Inc. (TAYD) is expected to report for Q1 2024 American Biltrite Inc. (ABLT) is expected to report for quarter end 2023-09-30 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for Q3 2024 ...
1st Cap Bancorp (FISB) is expected to report for Q3 2023 Timberline Resources Corp. (TLRS) is expected to report for Q1 2024 Engie Brasil Energia S.A. ADR (EGIEY) is expected to report for Q4 2023 NuZee Inc. (NUZE) is expected to report for quarter end 2023-09-30 Global Arena Hold...
Bexil Corp (BXLC) is expected to report for quarter end 2023-09-30 Daily Journal Corp. (S.C.) (DJCO) is expected to report for quarter end 2023-09-30 Arch Therapeutics Inc (ARTH) is expected to report $-0.13 for Q4 2023 First Republic Bank (San Francisco, California) (FRCB) is expecte...